Changes in Hemostatic Variables Induced by Estrogen Replacement Therapy: Comparison of Transdermal and Oral Administration in a Crossover-Designed Study-Reference-Cited by-同舟云学术

Changes in Hemostatic Variables Induced by Estrogen Replacement Therapy: Comparison of Transdermal and Oral Administration in a Crossover-Designed Study

Published:2007-08-22 Issue:1 Volume:65 Page:47-51
ISSN:0378-7346
Container-title:Gynecologic and Obstetric Investigation
language:en
Short-container-title:Gynecol Obstet Invest

Author:

Fait Tomas,Vrablik Michal,Zizka Zdenek,Kostirova Milada

Publisher

S. Karger AG

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference26 articles.

1. The clinical practice impact of the Women's Health Initiative: political vs biologic correctness

2. Tissue factor pathway inhibitor and the current concept of blood coagulation

3. Tissue factor pathway inhibitor: structure, biology and involvement in disease

4. Functional and immunologic methods for the measurement of human tissue factor pathway inhibitor

5. Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic thromboembolic pulmonary disease: Association with exercise-induced pulmonary hypertension and right ventricle adaptation over time;European Journal of Internal Medicine;2023-12

2. Pharmacokinetics of Sublingual Versus Oral Estradiol in Transgender Women;Endocrine Practice;2021-11

3. Hormone Replacement Therapy in Premature Ovarian Insufficiency;Menstrual Cycle Related Disorders;2019

4. From Primary Hypergonadotropic Amenorrhea to “POI”: Aetiology and Therapy;ISGE Series;2017

5. Interaction between oral estrogen plus progestogen therapy and ABO blood groups on coagulation activation in postmenopausal women;Menopause;2012-03